{{Rsnum
|rsid=2418087
|Gene=STYK1
|Chromosome=12
|position=10653686
|Orientation=plus
|GMAF=0.2727
|Gene_s=STYK1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 17.9 | 47.3 | 34.8
| HCB | 2.9 | 30.7 | 66.4
| JPT | 2.7 | 42.5 | 54.9
| YRI | 2.7 | 21.8 | 75.5
| ASW | 5.3 | 26.3 | 68.4
| CHB | 2.9 | 30.7 | 66.4
| CHD | 2.8 | 34.9 | 62.4
| GIH | 9.9 | 50.5 | 39.6
| LWK | 0.9 | 20.9 | 78.2
| MEX | 8.6 | 34.5 | 56.9
| MKK | 1.3 | 21.8 | 76.9
| TSI | 13.7 | 40.2 | 46.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=22688887
|Title=Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}